Company research
BIOETHICS LTD
CIK 894560Updated Sep 24, 2026
SecurityBOTH · OTC · equity
BOTH price & chart
Loading TradingView…
OTC:BOTH on TradingView ↗In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2024 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 14,664Source | 138Source | 295Source | 734Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 14,664Source | 138Source | 295Source | 734Source |
| Assets, CurrentUSD | 14,664Source | 138Source | 295Source | 734Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 945,884Source | 776,403Source | 679,411Source | 586,647Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 3,335Source | 1,135Source | 1,135Source | 1,135Source |
| Additional Paid in CapitalUSD | 520,279Source | 500,479Source | 500,479Source | 500,479Source |
| Retained Earnings (Accumulated Deficit)USD | -1,454,834Source | -1,277,879Source | -1,180,730Source | -1,087,527Source |
| Stockholders' Equity Attributable to ParentUSD | -931,220Source | -776,265Source | -679,116Source | -585,913Source |
| Liabilities and EquityUSD | 14,664Source | 138Source | 295Source | 734Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 945,884Source | 776,403Source | 679,411Source | 586,647Source |
| Accounts Payable, CurrentUSD | 192,788Source | 122,400Source | 100,265Source | 79,601Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | — | 98,363Source | 79,179Source | 58,615Source |
cash flow · annual statements
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -176,955Source | -97,149Source | -93,203Source | -107,183Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -150,429Source | -22,307Source | -25,639Source | -27,483Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | 0Source | 0Source | 0Source | 0Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 164,955Source | 22,150Source | 25,200Source | 27,550Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 14,664Source | 138Source | 295Source | — |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 85,000Source | — | — | — |
| Additional Financial Items | ||||
| DepreciationUSD | — | — | 0Source | 226Source |
| General and Administrative ExpenseUSD | 122,817Source | 50,442Source | 47,303Source | 59,367Source |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | -176,955Source | — | — | — |
| Nonoperating Income (Expense)USD | — | -46,707Source | -45,900Source | -47,816Source |
| Operating ExpensesUSD | 122,817Source | 50,442Source | 47,303Source | 59,367Source |
| Other Nonoperating Income (Expense)USD | -54,138Source | — | — | — |
income statement · annual statements
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Total RevenueUSD | 0Source | 0Source | 0Source | 0Source |
| Operating Income (Loss)USD | -122,817Source | -50,442Source | -47,303Source | -59,367Source |
| Other Nonoperating Income (Expense)USD | -54,138Source | — | — | — |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -176,955Source | -97,149Source | -93,203Source | -107,183Source |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | -176,955Source | — | — | — |
| Earnings Per Share, BasicUSD per share | — | -0.09Source | -0.08Source | -0.09Source |
| Earnings Per Share, DilutedUSD per share | -0.12Source | — | — | — |
| Weighted Average Number of Shares Outstanding, Basicshares | 1,493,117Source | 1,135,194Source | 1,135,194Source | 1,135,194Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 1,493,117Source | — | — | — |
| Additional Financial Items | ||||
| General and Administrative ExpenseUSD | 122,817Source | 50,442Source | 47,303Source | 59,367Source |
| Interest ExpenseUSD | 54,138Source | 46,707Source | 45,900Source | 47,816Source |
| Nonoperating Income (Expense)USD | — | -46,707Source | -45,900Source | -47,816Source |
| Operating ExpensesUSD | 122,817Source | 50,442Source | 47,303Source | 59,367Source |